Head and neck in situ carcinoma: incidence, trends, and survival
- PMID: 10964047
- DOI: 10.1016/s1368-8375(00)00028-2
Head and neck in situ carcinoma: incidence, trends, and survival
Abstract
This analysis describes the epidemiology of in situ head and neck carcinomas (anatomic sites of lip, oral cavity, pharynx, larynx) about which there is limited knowledge. Data were derived from nine population-based cancer registries participating in the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. SEER annual age-adjusted incidence rates for in situ head and neck carcinomas increased from 6.33/1,000,000 person-years (PY) in 1976 to 8.04/1,000,000 PY in 1995 [percent change (PC)=35%, P<0. 001]. From 1976 to 1995 age-adjusted changes in incidence by anatomic site ranged from 53% PC (larynx) to -11% PC (lip) (both P<0. 005). Incidence and survival associated with in situ head and neck carcinomas varied by anatomic site, age, sex, and race and did so in a pattern similar to that seen for invasive carcinomas of this region. However, the climbing incidence of in situ carcinoma, which may be related to increased surveillance, contrasts sharply with the declining incidence of invasive carcinoma.
Similar articles
-
Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.Oncologist. 2019 Dec;24(12):1562-1569. doi: 10.1634/theoncologist.2018-0054. Epub 2019 Aug 7. Oncologist. 2019. PMID: 31391295 Free PMC article.
-
Epidemiology of head and neck cancer in the United States.Otolaryngol Head Neck Surg. 2006 Sep;135(3):451-7. doi: 10.1016/j.otohns.2006.01.029. Otolaryngol Head Neck Surg. 2006. PMID: 16949981
-
Pediatric non-nasopharyngeal head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results (SEER) program with review of the literature.Int J Pediatr Otorhinolaryngol. 2024 Nov;186:112135. doi: 10.1016/j.ijporl.2024.112135. Epub 2024 Oct 15. Int J Pediatr Otorhinolaryngol. 2024. PMID: 39442194 Review.
-
Head and neck in situ carcinoma: survival analysis of the Thuringian cancer registration database.Oral Oncol. 2010 Apr;46(4):e5-9. doi: 10.1016/j.oraloncology.2010.01.005. Oral Oncol. 2010. PMID: 20227329
-
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2018;47(4):203-211. doi: 10.17849/insm-47-04-1-9.1. Epub 2019 Jan 22. J Insur Med. 2018. PMID: 30668210
Cited by
-
ASC contributes to metastasis of oral cavity squamous cell carcinoma.Oncotarget. 2016 Aug 2;7(31):50074-50085. doi: 10.18632/oncotarget.10317. Oncotarget. 2016. PMID: 27367024 Free PMC article.
-
Dissection of a metastatic gene expression signature into distinct components.Genome Biol. 2006;7(12):R117. doi: 10.1186/gb-2006-7-12-r117. Genome Biol. 2006. PMID: 17156469 Free PMC article.
-
Recombinant Porphyromonas gingivalis W83 FimA alters immune response and metabolic gene expression in oral squamous carcinoma cells.Clin Exp Dent Res. 2022 Aug;8(4):976-987. doi: 10.1002/cre2.588. Epub 2022 May 15. Clin Exp Dent Res. 2022. PMID: 35570325 Free PMC article.
-
In Vitro Study of Synergic Effect of Cisplatin and Low Molecular Weight Heparin on Oral Squamous Cell Carcinoma.Front Oncol. 2020 Nov 18;10:549412. doi: 10.3389/fonc.2020.549412. eCollection 2020. Front Oncol. 2020. PMID: 33312942 Free PMC article.
-
Induction of oxidative stress and cell apoptosis by selenium: the cure against oral carcinoma.Oncotarget. 2017 Nov 29;8(69):113614-113621. doi: 10.18632/oncotarget.22752. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371933 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical